Meet DiagNoze®

Set to become the world's most advanced diagnostic breathalyzer, it will be fully-integrated, cost-effective and deliver results in real-time from any point-of-care. Now, that's breathtaking.

DiagNoze® is under development and has not been approved, cleared, or authorized by the U.S. Food and Drug Administration (FDA), or any other health authority or regulatory body worldwide.  DiagNoze® is not available for commercial sale.

The world’s first fully-integrated breathalyzer for screening and diagnostics powered by Noze’s proprietary digital odor perception platform. DiagNoze is set to unlock a new dimension of medical diagnostics and completely transform the way we think about healthcare. Imagine being able to conduct routine screenings and diagnose diseases with a single exhale from any point-of-care setting from the hospital to the home. Now, that’s breathtaking.

The world’s first fully-integrated breathalyzer for screening and diagnostics powered by Noze’s proprietary digital odor perception platform. DiagNoze is set to unlock a new dimension of medical diagnostics and completely transform the way we think about healthcare. Imagine being able to conduct routine screenings and diagnose diseases with a single exhale from any point-of-care setting from the hospital to the home. Now, that’s breathtaking.

The world’s first fully-integrated breathalyzer for screening and diagnostics powered by Noze’s proprietary digital odor perception platform. DiagNoze is set to unlock a new dimension of medical diagnostics and completely transform the way we think about healthcare. Imagine being able to conduct routine screenings and diagnose diseases with a single exhale from any point-of-care setting from the hospital to the home. Now, that’s breathtaking.

At the front-end of our platform lies the Noze aroma chip - a digital equivalent of the nose’s olfactory receptors. Each breath sample that passes over the aroma chip produces a unique “digital scentprint” that is loaded with health information.

Next sits Noze’s proprietary multi-layered perceptive AI engine. It will apply a complex series of algorithms to precisely interpret the digital scentprint, with the potential to identify disease biomarkers regardless of what else might be lingering in the background.

There will be no need to send samples to a lab for analysis with DiagNoze®. Results will be instantly processed in the cloud, allowing for seamless, real-time integration with nearly any electronic medical record (EMR) system.

Let’s talk

Interested in learning more about one of our clinical studies? Got a question, or ten? Leave us your details below, and one of our experts will get in touch.

Thanks for contacting us!
One of Noze's team members will reach out to you shortly.
Oops! Something went wrong while submitting the form.